Riskpilot← Back to searchSign inGet full accessHK Chirodonti AB
ABActiveOrg 5569061236Grubbensgatan 2Dental practice care activities · NACE 8623Est. 20129 employees
Revenue 2024
SEK 20,8M
-1% vs 2023
EBITDA margin
5.2%
-70% vs 2023
Equity ratio
8.8%
Financial strength
Net profit 2024
SEK 148K
-93% vs 2023
| Revenue | SEK 20,8M | -1% |
| EBITDA | SEK 1,1M | -70% |
| Net profit | SEK 148K | -93% |
| Total assets | SEK 6,7M | +10% |
| Equity | SEK 590K | -53% |
| Employees | 9 | — |
Legal name
HK Chirodonti AB
Org number
5569061236
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
8 oktober 2012
Share capital
SEK 50 000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsulttjänster inom tandvård, handel med utrustning och material inom oralkirurgi samt därmed förenlig verksamhet.
Address
Grubbensgatan 2
Email
hai_kandi@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 413 | 4 188 | 10 276 | 20 976 | 20 844 |
| Staff expenses | — | — | −3 666 | −5 285 | −4 864 |
| EBITDA | −12 | −182 | 545 | 3 646 | 1 086 |
| Depreciation & amort. | −84 | −429 | −512 | −526 | −605 |
| EBIT | −96 | −611 | 33 | 3 120 | 481 |
| Net financials | −6 | −177 | −197 | −276 | −272 |
| Profit before tax | −102 | −788 | −164 | 2 344 | 209 |
| Tax | −0 | −0 | — | −252 | −61 |
| Net profit | −102 | −788 | −164 | 2 091 | 148 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 917 | 4 306 | 4 585 | 6 111 | 6 729 |
| Equity | 119 | −668 | −832 | 1 259 | 590 |
| Long-term debt | 2 352 | 4 102 | 3 070 | 2 383 | 2 896 |
| Short-term debt | 446 | 872 | 2 348 | 1 969 | 2 797 |
| Total debt | 2 798 | 4 974 | 5 418 | 4 352 | 5 693 |
EBITDA margin
5.2%
This company
15.8%
Market median
-67% vs market
20202024
Equity ratio
8.8%
This company
38.2%
Market median
-77% vs market
20202024
Return on equity
25.1%
This company
18.4%
Market median
+36% vs market
20202024
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
20202024
Asset turnover
3.10×
This company
1.12×
Market median
+177% vs market
20202024
Debt / equity
10.41×
This company
0.62×
Market median
-1579% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ET Chief Auditor | Chief Auditor | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
UA | Deputy Board Member | 2022 |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HK Chirodonti AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Tobias Wiklund | Chief Auditor | 0 companies |
| Ula Afif | Deputy Board Member | 0 companies |
| Haitham Akram Afif | Board of Directors | 0 companies |